Folegatti PM, Bittaye M, Flaxman A, Lopez FR, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020 Apr 20. pii: S1473-3099(20)30160.
PMID: 32325038